WHO: Countries need to diversify vaccine portfolio - News Summed Up

WHO: Countries need to diversify vaccine portfolio


Supply security“Because of the supply situation, most countries are likely going to have to use more than one product. We do need multiple products in the marketplace … and getting that supply security is really important,” said Kate O’Brien, the WHO’s director for immunization, vaccines, and biologicals. PH procurement planUnder the Philippines’ vaccine procurement plan, Science Undersecretary Rowena Cristina Guevara said the target was for the country to secure at least one candidate vaccine from each of the five vaccine platforms. To that effect we need to make sure we can get as many vaccines from all the types of platforms,” she said. Other COVID-19 vaccine platforms include recombinant protein (used by Novovax and Anhui Zhifei Biopharmaceuticals), viral vector (Oxford/AstraZeneca, Gamaleya, and Johnson&Johnson), and inactivated (Sinovac and Sinopharm).


Source: Philippine Daily Inquirer December 20, 2020 21:00 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */